A Three-in-one ZIFs-Derived CuCo(O)/GOx@PCNs Hybrid Cascade Nanozyme for Immunotherapy/Enhanced Starvation/Photothermal Therapy.

Autor: Wang Q; College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao 266109, China., Niu D; Department of Gastrointestinal Surgery, Affiliated Hospital of Qingdao University, 59 Haier Road, Qingdao, Shandong 266071, China., Shi J; College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao 266109, China., Wang L; Science and Information College, Qingdao Agricultural University, Qingdao 266109, China.
Jazyk: angličtina
Zdroj: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2021 Mar 17; Vol. 13 (10), pp. 11683-11695. Date of Electronic Publication: 2021 Mar 03.
DOI: 10.1021/acsami.1c01006
Abstrakt: Glucose oxidase (GOx) is regarded as an ideal endogenous natural enzyme for tumor starvation therapy and photothermal therapy (PTT) is a promising strategy for the ablation of primary tumor. In this work, Cu-doped cobalt oxide and porous carbon nanocomposites (CuCo(O)@PCNs) were synthesized from double-layered ZIF-8@ZIF-67 and GOx was loaded in the porous carbon to form a CuCo(O)/GOx@PCNs hybrid nanozyme. CuCo(O) was characterized as the Cu 0.3 Co 2.7 O 4 phase through X-ray diffraction analysis and it can react with H 2 O 2 to generate O 2 and alleviate tumor hypoxia, resulting in the recovered enzymatic activity of GOx and the enhanced starvation therapy. The porous nanocarbon can ablate the primary tumor because of its high photothermal conversion efficiency of 40.04%. The three-in-one functions of oxygen supply, glucose consumption, and photothermal conversion were realized in the ZIFs-derived CuCo(O)/GOx@PCNs nanozyme and the starvation therapy effect was improved by PTT and oxygen supplement. Furthermore, the inhibition effect of CuCo(O)/GOx@PCNs on metastatic tumor is similar to combined therapy of the nanozyme and the immune checkpoint-blocking antibody, α-PD-1. The related antitumor immune mechanism was studied through the analysis of immune-related proinflammatory cytokines and the activated T cells. This work may provide new ideas for the development and application of the ZIFs-derived hybrid nanozyme in tumor therapy and the CuCo(O)/GOx@PCNs nanozyme may be a promising alternative to immune checkpoint inhibitors.
Databáze: MEDLINE